The Centers for Disease Control (CDC) invites providers, patients, and organization representatives to provide input on Draft CDC Opioid Prescribing Guidelines for Chronic Pain during a webinar presentation and discussion from 2:30-4 p.m. EST Sept. 16.
The recommendations are intended for the prescribing of opioid pain relievers for patients 18 and older with chronic pain, in primary care settings, outside end-of-life care. CDC wants to present the draft recommendations that have been informed by the scientific evidence and developed through discussion with experts. CDC is seeking input so that we are able to improve the content, clarity, and utility of the draft recommendations.
During the webinar, CDC experts will walk through the guideline development process and the 12 top-line prescribing recommendations. CDC will pause for webinar participants to provide comments for each recommendation. Participants can submit comments 1) orally over the phone, 2) in writing in real-time via the webinar portal, or 3) via email immediately after the webinar and up through 5 p.m. EST Sept. 17.
CDC will summarize public comments and provide responses to comments in a document that will be posted on the NCIPC Peer Review Agenda website in October. The written summary will be anonymous and will not include names of individuals or organizations submitting comments.
How to Register and Join the Webinar:
To register and learn more about this event, visit: https://events-na12.adobeconnect.com/content/connect/c1/1278955669/en/events/catalog.html. Find the link to the CDC Opioid Prescribing Guidelines Public Webinar, and click “register.” Once registered, an email will be sent to you containing a link to the webinar for use on the day of the presentation. A conference line will be displayed once the webinar begins.
Given the limited lines available via the webinar platform, participants must register in advance in order to join. Organizations that anticipate having multiple participants join the webinar are encouraged to use a single line and computer, if feasible, to ensure broad participation in the webinar.
VER TAMBIÉN:
CADCA’s Prevent Rx Abuse website with National Medicine Abuse Awareness Month information